About the Cognistat cognition screening test
The original Cognistat Paper Test, formerly known as the Neurobehavioral Cognitive Status Examination (NCSE), is a cognitive test instrument that screens for cognistive impairment.
Cognistat was developed in 1979 at Stanford University by Drs. Ralph Kiernan, Jonathan Mueller and J. William Langston. A global leader in rapid cognitive assessment, Cognistat avoids aggregate scoring by testing in five major areas of brain function: Language, Construction, Memory, Calculation and Reasoning with separate scoring in each.
Administered by Healthcare Professionals, the web or paperbased solution test results are depicted graphically and used to determine the level of impairment and its possible cause, thus assisting in patient diagnosis.
Cognistat’s cognitive assessments have been fully standardized for adolescents, adults and also for seniors in three age groups: (60–64, 65–74 and 75–84). More than 400 peer-reviewed scientific articles describe Cognistat's use in patients with stroke, dementia, traumatic brain injury, major psychiatric disorders and substance abuse.
These data are provided by both Cognistat and 3rd parties in peer-reviewed clinical reports in multiple languages.
Cognistat has an extensive body of literature reports that describe is use as a cognitive impairment assessment test in the fields of Stroke, Dementia, Rehabilitation Medicine, Occupational Therapy, Geriatric Nursing, Mild Cognitive Impairment, Elderly Care, Traumatic Brain Injury, Addiction, Neurosurgery, Neuropsychology, Psychiatry, Epilepsy, Parkinson’s Disease and PTSD domains.
Cognistat is uniquely attentive to shifting state factors, medical issues and current medications. By asking the examiner to determine the presence or absence of specific factors, Cognistat alerts the examiner to the impact that shifting state variables can have on test performance. This decreases the risk that examiners will arrive at false positive conclusions and underscores the importance of repeat testing whenever factors have changed or been modified by treatment.
Efficient and cost effective, any health care system, hospital, VA center, private clinic or practice that has the need to administer a cognitive assessment for following conditions can use Cognistat: Alzheimer.s Dementia, Stroke Victims, TBI, PTSD. It’s high degree of sensitivity and validity, make it an ideal tool for cognistive screening.
The Grauer Psychology Center use Cognistat as part of its cognistion screening service.